http://rdf.ncbi.nlm.nih.gov/pubchem/reference/31573195

Outgoing Links

Predicate Object
contentType Case Reports|Journal Article
endingPage 557
issn 1699-048X
1699-3055
issueIdentifier 8
pageRange 554-557
publicationName Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
startingPage 554
bibliographicCitation Mendiola C, Vaz MÁ. Is capecitabine a new choice of treatment for lung adenocarcinoma? A case report involving partial response in second line of treatment and hypothesis of the biological basis. Clinical and Translational Oncology. 2009 Aug 29;11(8):554–7. doi: 10.1007/s12094-009-0403-1.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_51049c28960f42d1fc84159d863014f3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_08422f008c1b6e9eae4fc9fd6058bf6b
date 2009-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1007/s12094-009-0403-1
https://pubmed.ncbi.nlm.nih.gov/19661033
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/32427
https://portal.issn.org/resource/ISSN/1699-048X
https://portal.issn.org/resource/ISSN/1699-3055
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Is capecitabine a new choice of treatment for lung adenocarcinoma? A case report involving partial response in second line of treatment and hypothesis of the biological basis
discusses http://id.nlm.nih.gov/mesh/M0001471
http://id.nlm.nih.gov/mesh/M0008631
http://id.nlm.nih.gov/mesh/M0005997
http://id.nlm.nih.gov/mesh/M0287377
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1325271ceb6ced42974ded478396cd87
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71296871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176870
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.4.2.4
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46931011
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3f5453e192e572cbc2bed32097c7aaaf
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44424639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73265388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135410875
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7168
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60780
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13200033
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135945851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136123131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128204655
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127639621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129221764
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127952853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127377427

Total number of triples: 57.